shiftzero k k
ShiftZero K.K. is a Tokyo-based B2B pharmaceutical services firm supporting drug development and commercialization through consulting, clinical planning, trial-design consultation, promotional materials, events, and market research for pharmaceutical companies throughout the product lifecycle.
- Company typePrivate
- Founded2014
- HeadquartersTokyo, Japan
- Headcount—
- GTM typeB2B
- OfferingServices
What shiftzero k k does
ShiftZero K.K. is a privately held Tokyo-based B2B professional-services company founded on November 19, 2014, that supports pharmaceutical companies across the drug lifecycle. Its Consulting Division provides market research and analysis, development plans, trial design, clinical-trial consultation, promotion strategy, and post-marketing clinical study planning. Its Marketing Division creates medical and promotional materials, supports publications, plans advisory boards, lectures, and congress exhibitions, and conducts physician qualitative research and patient journey mapping.
The operating model coordinates development-stage work with post-marketing activities and feeds real-world clinical-practice insights back into development planning, with the stated aim of supporting product introduction and branding across phases. Clients engage the firm through direct, personalized B2B contact initiated through its website or email inquiries. Pricing, headcount, revenue, customer counts, proprietary technology, and measurable outcomes are not disclosed; its disclosed distribution footprint is domestic Japan, and the operating model is professional services rather than product or subscription revenue.
shiftzero k k firmographics
Firmographics- Name
- shiftzero k k
- Legal name
- 株式会社シフトゼロ
- Website
- https://shiftzerokk.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Short description
- ShiftZero K.K. is a Tokyo-based B2B pharmaceutical services firm supporting drug development and commercialization through consulting, clinical planning, trial-design consultation, promotional materials, events, and market research for pharmaceutical companies throughout the product lifecycle.
- Ownership category
- akta.pro rank
shiftzero k k industry classification
Industry- Product category
- Pharmaceutical Consulting Services
- NAICS
- Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
- akta.pro secondary industry
- Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where shiftzero k k is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
shiftzero k k business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Consulting Services: ShiftZero K.K. generates revenue through consulting and professional services for pharmaceutical companies, including market research, strategic development planning, clinical trial design, regulatory consultation, and post-marketing promotional activities. Services are provided throughout the entire drug lifecycle.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
shiftzero k k product offering
Product offeringCore offering
ShiftZero K.K. is a pharmaceutical consulting firm that supports pharmaceutical companies across the entire drug lifecycle. Through its Consulting Division, the company delivers market research, strategic development planning, trial design, clinical trial consultation, and promotion strategy development. Through its Marketing Division, it produces medical and promotional materials, manages publication support, plans advisory boards and medical congresses, and runs physician qualitative surveys and patient journey mapping for pharmaceutical clients.
Product overview
ShiftZero K.K. is a pharmaceutical consulting company that provides integrated services throughout the entire drug lifecycle. The company operates through two main divisions: the Consulting Division handles market research, strategic development planning, trial design, and clinical consultation, while the Marketing Division manages creation of promotional and educational materials, publication support, meeting and event planning, and market research services. Together, these divisions coordinate to support drug development from planning through post-marketing promotional activities.
Differentiator
Problem solved
Functional benefit
Products and services
- Consulting Division Services (コンサルティング部門)
- Marketing Division Services (マーケティング本部)
Companies that use shiftzero k k
Customer profileSegments1 record
Ideal customer profiles1 record
shiftzero k k technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
shiftzero k k partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- Artemida PharmaminorArtemida Pharma is listed as a business partner on ShiftZero K.K.'s website. The partnership appears to be a strategic alliance within the pharmaceutical services ecosystem.
- CMIC Holdings Co., Ltd. (シミックホールディングス株式会社)minorCMIC Holdings, a major Japanese pharmaceutical services company (CRO), is listed as a business partner. CMIC provides contract research organization services, potentially complementing ShiftZero's lifecycle management offerings.
- Prescient Healthcare GroupminorPrescient Healthcare Group, a healthcare intelligence company, is listed as a business partner. The partnership may provide strategic intelligence capabilities to support ShiftZero's consulting and marketing services.
Recent moves3 records
Expansion highlights3 records
shiftzero k k competitors and assessment
Company assessmentBroad incumbents
- CMIC Holdings: Japan's largest CRO and listed pharma-services platform offering clinical development, post-marketing services, and consulting. Listed as a ShiftZero business partner, CMIC operates one rung up the value chain with the same pharma sponsor base but at markedly greater scale and breadth.
- IQVIA Japan: Global leader in clinical research, real-world evidence, and pharma consulting with a substantial Japan presence. Competes for the same strategic-development and post-marketing advisory mandates that ShiftZero targets among Japanese pharma sponsors.
- EPS Holdings: Japanese CRO and healthcare services group offering clinical research, post-marketing, and CRO-related consulting. Significantly larger than ShiftZero with an overlapping pharma-sponsor client base in Japan.
- ZS Associates: Global management consulting firm with a large pharma and life sciences practice covering strategy, launch planning, and commercial operations — addressing the same client problem space as ShiftZero but at much greater scale and geographic reach.
- McKinsey & Company (Pharma Practice): Global top-tier management consulting firm with a deep pharma and medical-products practice advising on strategy, R&D, and commercial excellence — competes for the same high-stakes lifecycle and launch mandates as ShiftZero.
Direct peers
- Prescient Healthcare Group: Healthcare intelligence and strategic advisory firm that supports pharma clients with competitive intelligence, market research, and pipeline strategy — overlapping squarely with ShiftZero's Consulting Division services and also a ShiftZero partner.
- A2 Healthcare Corporation: Japan-based CRO/clinical services firm spun off from a major Japanese pharma, providing clinical development and post-marketing support to pharma companies — directly comparable in service mix and target buyer to ShiftZero.
- INTAGE Healthcare: Japanese market-research and consulting firm focused on healthcare/pharma, providing physician surveys, patient journey analysis, and market insight — directly overlapping with ShiftZero's market-research and physician qualitative survey offerings.
Emerging players
- Artemida Pharma: Pharma-focused strategic partner listed on ShiftZero's partner page, operating in the Japanese pharma services ecosystem with overlapping capabilities around development strategy and commercialization support for emerging/specialty pharma.
Regional players
- Medipal Holdings (Pharma Services): Major Japanese pharma distribution and services group whose services arm supports pharma manufacturers with post-marketing and commercial support functions. Comparable buyer type (Japan pharma manufacturers) and adjacent capability footprint to ShiftZero.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat1 record
Key risks5 records
Key highlights5 records
Customer concentration
shiftzero k k social profiles
Digital presenceshiftzero k k financial estimates
Financial estimateRevenue estimate
Valuation estimate
shiftzero k k leadership team
Management profileNumber of profiles
Profiles1 record
shiftzero k k funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
shiftzero k k M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about shiftzero k k
What does shiftzero k k do?
ShiftZero K.K. is a pharmaceutical consulting firm that supports pharmaceutical companies across the entire drug lifecycle. Through its Consulting Division, the company delivers market research, strategic development planning, trial design, clinical trial consultation, and promotion strategy development. Through its Marketing Division, it produces medical and promotional materials, manages publication support, plans advisory boards and medical congresses, and runs physician qualitative surveys and patient journey mapping for pharmaceutical clients.
Is shiftzero k k a public or private company?
shiftzero k k is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was shiftzero k k founded?
shiftzero k k was founded in 2014.
Where is shiftzero k k based?
shiftzero k k is headquartered in Tokyo, Japan, in the Asia region.
How does shiftzero k k make money?
One revenue line is on record: consulting Services.
Who are shiftzero k k's main competitors?
Broad incumbents on record are CMIC Holdings, IQVIA Japan, EPS Holdings, ZS Associates and McKinsey & Company (Pharma Practice). Direct peers are Prescient Healthcare Group, A2 Healthcare Corporation and INTAGE Healthcare. Artemida Pharma is listed as an emerging player. Medipal Holdings (Pharma Services) is listed as a regional player.
Does shiftzero k k have an API?
No public API is recorded for shiftzero k k.
What industry is shiftzero k k in?
shiftzero k k's product category is Pharmaceutical Consulting Services. Its primary akta.pro industry code is HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC), with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 54161 and its SIC code is 8742.